New Jersey A 692: Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

Status: Introduced, Referred to Assembly Education Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: A 692

Sponsors: Kanitra, Paul, McGuckin, Gregory P.

View New Jersey A 692 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.